phenyl l-ornithine acetate salt production processes, method of compressing phenyl l-ornithine acetate and use of therapeutically effective amount of crystalline form of phenyl l-ornithine acetate salt

摘要

Disclosed herein are crystalline forms of L-ornithine phenyl acetate and methods of making the same. The crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.